Clinical Trial

Personalized Blood Transfusion Protocol for Cardiac Patients

Study acronym: PerP
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study compares two accepted ways of deciding when adults recovering from open-heart surgery should receive a blood transfusion in the intensive care unit. One approach gives a transfusion when the blood count (hemoglobin) falls below a fixed level that is the same for everyone. The other approach adds each patient's own physiology - such as oxygen levels and lactate - to help decide whether a transfusion is truly needed, within a safe range. The investigators want to learn whether the personalized approach is as safe as the standard approach for major outcomes after heart surgery, while reducing the amount of blood transfused. Participants may also choose to give blood and stool samples to a research biobank for future studies on recovery after cardiac surgery.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-06-22.
Trial Details
NCT Number NCT07671469
Lead Sponsor Yan Mia Min
Collaborators: Stanford University
Conditions Cardiac Surgery, Blood Transfusion, Anemia, Cardiopulmonary Bypass
Enrollment 900 participants
Start Date 2026-09-14
Primary Completion 2029-10-19 (estimated)
Study Completion 2030-03-15 (estimated)
Updated on ClinicalTrials.gov 2026-06-30